Duration and cost-effectiveness of hepatocellular carcinoma surveillance in hepatitis C patients after viral eradication

Hepatocellular carcinoma risk in hepatitis C stage‐3 fibrosis after sustained virological response with direct‐acting antivirals

(2021) María Sánchez‐Azofra et al.   LIVER INTERNATIONAL

Incidence of HCC in chronic hepatitis C patients with advanced hepatic fibrosis who achieved SVR following DAAs: A prospective study

(2020) Gamal Shiha et al.   JOURNAL OF VIRAL HEPATITIS

Assessment of Incidence of and Surveillance Burden for Hepatocellular Carcinoma Among Patients With Hepatitis C in the Era of Direct-Acting Antiviral Agents

(2020) Qiushi Chen et al.   JAMA Network Open

Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study

(2019) Fabrice Carrat et al.   LANCET

For Whom is Hepatocellular Carcinoma Surveillance after Sustained Virologic Response Cost-Effective?

(2019) Amit G. Singal et al.   Clinical Gastroenterology and Hepatology

Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents

(2019) Fasiha Kanwal et al.   HEPATOLOGY

Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs

(2018) Pierre Nahon et al.   GASTROENTEROLOGY

Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents

(2018) Vincenza Calvaruso et al.   GASTROENTEROLOGY

The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study

(2018) Darrick K. Li et al.   HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2018) Peter R. Galle et al.   JOURNAL OF HEPATOLOGY

Screening for Cervical Cancer in Primary Care

(2018) Jane J. Kim et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Hepatocellular Carcinoma Screening is Associated with Increased Survival of Patients with Cirrhosis

(2018) Debra T. Choi et al.   Clinical Gastroenterology and Hepatology

Cost-effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With HCV Infection and Advanced Fibrosis

(2018) Hooman Farhang Zangneh et al.   Clinical Gastroenterology and Hepatology

Risk for Hepatocellular Carcinoma After Hepatitis C Virus Antiviral Therapy With Direct-Acting Antivirals: Case Closed?

(2017) Raoel Maan et al.   GASTROENTEROLOGY

Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents

(2017) Fasiha Kanwal et al.   GASTROENTEROLOGY

Poor adherence to hepatocellular carcinoma surveillance: A systematic review and meta-analysis of a complex issue

(2017) Changqing Zhao et al.   LIVER INTERNATIONAL

Lipid-modifying effects of krill oil in humans: systematic review and meta-analysis of randomized controlled trials

(2017) Sorin Ursoniu et al.   NUTRITION REVIEWS

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis

(2017) Nicolas Goossens et al.   Clinical and Translational Gastroenterology

Hepatitis C Disease Burden in the United States in the era of oral direct-acting antivirals

(2016) Jagpreet Chhatwal et al.   HEPATOLOGY

Estimation of Benefits, Burden, and Harms of Colorectal Cancer Screening Strategies

(2016) Amy B. Knudsen et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment

(2016) Wei Yang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Longterm survival outcomes of patients undergoing treatment with radiofrequency ablation for hepatocellular carcinoma and metastatic colorectal cancer liver tumors

(2016) Iswanto Sucandy et al.   HPB

Prognostic factors of hepatocellular carcinoma survival after radiofrequency ablation: A US population-based study

(2016) Mohamed Abd El-Fattah et al.   United European Gastroenterology Journal

Screening for Hepatocellular Carcinoma in Chronic Liver Disease

(2015) Diana Chirovsky et al.   ANNALS OF INTERNAL MEDICINE

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Screening for Hepatocellular Carcinoma in Chronic Liver Disease

(2014) Devan Kansagara et al.   ANNALS OF INTERNAL MEDICINE

Hepatocellular carcinoma: Diagnostic criteria by imaging techniques

(2014) Maxime Ronot et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

Updating Cost-Effectiveness — The Curious Resilience of the $50,000-per-QALY Threshold

(2014) Peter J. Neumann et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis

(2014) Amit G. Singal et al.   PLOS MEDICINE

Tipping the Balance of Benefits and Harms to Favor Screening Mammography Starting at Age 40 Years

(2013) Nicolien T. van Ravesteyn   ANNALS OF INTERNAL MEDICINE

Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach

(2013) Abbas Mourad et al.   HEPATOLOGY

Cost-Effectiveness of Boceprevir in Patients Previously Treated for Chronic Hepatitis C Genotype 1 Infection in the United States

(2013) Jagpreet Chhatwal et al.   VALUE IN HEALTH

Improving Hepatocellular Carcinoma Screening: Applying Lessons From Colorectal Cancer Screening

(2012) Amit G. Singal et al.   Clinical Gastroenterology and Hepatology

Whither hepatocellular carcinoma screening?

(2012) Morris Sherman   HEPATOLOGY

Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment

(2011) Adriana Toro et al.   SURGICAL ONCOLOGY-OXFORD

Trends in Organ Donation and Transplantation in the United States, 1999-2008

(2010) R. A. Wolfe et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States

(2010) Avo Artinyan et al.   CANCER

Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis

(2010) Ana-Carolina Cardoso et al.   JOURNAL OF HEPATOLOGY

Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis

(2009) A. SINGAL et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis

(2008) J Thompson Coon et al.   BRITISH JOURNAL OF CANCER

Cost Effectiveness of Alternative Surveillance Strategies for Hepatocellular Carcinoma in Patients With Cirrhosis

(2008) Karin L. Andersson et al.   Clinical Gastroenterology and Hepatology

The burden of illness associated with hepatocellular carcinoma in the United States

(2008) Kathleen Lang et al.   JOURNAL OF HEPATOLOGY

Mapping the English and Chinese Versions of the Functional Assessment of Cancer Therapy–General to the EQ-5D Utility Index

(2008) Yin-Bun Cheung et al.   VALUE IN HEALTH